| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/16/2003 | US20030014124 Method for debriding bone, and bone debrided thereby |
| 01/16/2003 | US20030013867 Translation enhancer element of the human amyloid precursor protein gene |
| 01/16/2003 | US20030013866 Eukaryotic cells expressing the receptor |
| 01/16/2003 | US20030013855 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/16/2003 | US20030013765 Fluid therapy with l-lactate and/or pyruvate anions |
| 01/16/2003 | US20030013667 Therapeutic agent for ischemia which inhibits apoptosis under ischemic condition |
| 01/16/2003 | US20030013649 Hybrid polypeptide |
| 01/16/2003 | US20030013645 Central nervous system disorders; Alzheimer's disease; Parkinson's disease |
| 01/16/2003 | US20030013638 P27 prevents cellular migration |
| 01/16/2003 | US20030013636 Prevent biosynthesis of galactoside |
| 01/16/2003 | US20030013197 Generation of adenovirus associated vector cultures; obtain cells, infect with expression vector, express vector and recover viral particles |
| 01/16/2003 | US20030013194 Prevention of membrane formation; obtain cell tissue, incubate with inhibitory collagen, monitor membrane formation |
| 01/16/2003 | US20030013193 Culturing preferential neurons; obtain neurons, incubate with mitogenic agent, graft cells, monitor differentiation in to neurons |
| 01/16/2003 | US20030013192 Method for neural stem cell differentiation using valproate |
| 01/16/2003 | US20030013191 Transgenic cells for use in human therapeutics and diagnostics |
| 01/16/2003 | US20030013190 Altered strain of the modified vaccinia virus ankara (mva) |
| 01/16/2003 | US20030013174 Genes for lysine biosynthetic system derived from thermophilic bacteria |
| 01/16/2003 | US20030013169 Transcription factor E2F DNA-binding domain inhibitor peptides and their use |
| 01/16/2003 | US20030013162 Interferon-epsilon |
| 01/16/2003 | US20030013158 Delta subunit of human GABAA receptor |
| 01/16/2003 | US20030013157 Culturing cells which generate preferential immunoglobulins; obtain cell, transform cell, recover cell expressing preferential immunoglobulin, isolate immunoglobulin |
| 01/16/2003 | US20030013153 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/16/2003 | US20030013149 Quantitative analysis |
| 01/16/2003 | US20030013144 Detection of modulator of cancer activity; obtain sample containing biopolymers, incubate with modulator, monitor cellular response |
| 01/16/2003 | US20030013143 Methods for identifying vasoprotective agents |
| 01/16/2003 | US20030013139 Transgenic cells for use as diagnostic tools in genetic engineering |
| 01/16/2003 | US20030013123 Isolation of trophoblast cells; obtain blood cells, incubate with binding agent, recover cells |
| 01/16/2003 | US20030013108 Novel RIP3 associated cell cycle proteins, compositions and methods of use |
| 01/16/2003 | US20030013107 Alpha 2 integrin: modulators of lymphocyte activation |
| 01/16/2003 | US20030013102 D-hydantoinase from Ochrobactrum anthropi |
| 01/16/2003 | US20030013095 Nuclcic acid enzyme for use in the prevention and treatment of infections and cancer |
| 01/16/2003 | US20030013087 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis |
| 01/16/2003 | US20030013081 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
| 01/16/2003 | US20030013079 Generation of preferential viral particle; obtain cells, transform with expresion vector, culture cell, recover viral particle |
| 01/16/2003 | US20030013078 Expression vector for use in the prevention and treatment of vial infection |
| 01/16/2003 | US20030013077 Binding to monoclonal antibodies; detection of Kaposi's sarcoma |
| 01/16/2003 | US20030013076 Viral vector for use as tool in genetic engineering and human therapeutics |
| 01/16/2003 | US20030013075 Diagnosing tumors in animal cells; obtain cells, detect expression of cancer marker gene, amplified concentration of marker gene expression indicates cancer |
| 01/16/2003 | US20030012823 Submucosa gel compositions |
| 01/16/2003 | US20030012822 Forming a shape retaining gel by enzymatically hydrolyzing warm-blooded vertebrate submucosa; fractionating the hydrolysate; and gelling by adjusting the pH to 6.0-8.0; suitable for inducing cell proliferation and growth |
| 01/16/2003 | US20030012805 Implant for cartilage tissue regeneration |
| 01/16/2003 | US20030012791 Use of cytokines and mitogens to inhibit graft versus host disease |
| 01/16/2003 | US20030012790 Especially bispecific molecules comprising an IFN- gamma inhibitor and a further specificity to a target involved in the initiation or development of IBD, including ulcerative colitis and Crohn's disease. |
| 01/16/2003 | US20030012787 Especially for ulcerative colitis and Crohn's disease. |
| 01/16/2003 | US20030012772 Methods for improving cell line activity in immunoisolation devices |
| 01/16/2003 | US20030012770 Recombinant p53 adenovirus methods and compositions |
| 01/16/2003 | US20030012769 Wherein a part or all of a regulatory element of the U3 region of the 5' LTR is replaced by another regulatory element, operable in a mammalian cell, which is not endogenous to said lentivirus. |
| 01/16/2003 | US20030012767 Tissue-specific taanscriptional regulatory sequence operably linked to the coding region of a gene that is essential for replication of said vector. |
| 01/16/2003 | CA2812821A1 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences |
| 01/16/2003 | CA2812799A1 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences |
| 01/16/2003 | CA2488550A1 A bioprocess for producing uniform embryoid bodies from embryonic stem cells in a high density bioreactor |
| 01/16/2003 | CA2467006A1 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 01/16/2003 | CA2453100A1 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 01/16/2003 | CA2453098A1 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 01/16/2003 | CA2453068A1 Mesenchymal cells and osteoblasts from human embryonic stem cell |
| 01/16/2003 | CA2453062A1 Group b streptococcus bvh-a5 antigens and corresponding dna fragments |
| 01/16/2003 | CA2452695A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | CA2452691A1 Dendritic cell isolation methods |
| 01/16/2003 | CA2452651A1 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences |
| 01/16/2003 | CA2452501A1 Secreted proteins |
| 01/16/2003 | CA2452315A1 Expression of functional human olfactory cyclic nucleotide gated (cng) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators |
| 01/16/2003 | CA2452119A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | CA2451492A1 Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms |
| 01/16/2003 | CA2451395A1 Novel pgc-1 isoforms and uses therefor |
| 01/16/2003 | CA2451374A1 Aggrecanase molecules |
| 01/16/2003 | CA2451055A1 Xenogenic oligoor/and polyribonucleotides as agents for the treatment of malignant tumours |
| 01/16/2003 | CA2450236A1 Phage displayed pdz domain ligands |
| 01/15/2003 | EP1275720A2 Histidyl-trna synthetase of staphylococcus aureus |
| 01/15/2003 | EP1275400A1 Therapeutic composition of non MHC-restricted T-cells/NK-cells and MHC-restricted cells for the treatment of tumors |
| 01/15/2003 | EP1274853A1 Materials and methods relating to immune responses to fusion proteins |
| 01/15/2003 | EP1274851A1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide |
| 01/15/2003 | EP1274849A2 Protein phosphatases |
| 01/15/2003 | EP1274845A2 Lipid binding protein 3 |
| 01/15/2003 | EP1274844A2 G-protein coupled receptors and nucleic acids encoding same |
| 01/15/2003 | EP1274843A1 New lipid binding protein 2 |
| 01/15/2003 | EP1274842A2 Lipid binding protein 4 |
| 01/15/2003 | EP1274841A2 Regulation of human cyslt2-like gpcr protein |
| 01/15/2003 | EP1274839A2 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor |
| 01/15/2003 | EP1274834A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2003 | EP1274833A2 A method to prevent graft rejection using tgf-beta to induce t suppressor cells |
| 01/15/2003 | EP1274832A1 L-leucyl-l-leucine methyl ester treatment of donor lypmhocyte infusions in hematopoietic stem cell transplant patients |
| 01/15/2003 | EP1274729A2 G protein coupled receptor |
| 01/15/2003 | EP1274728A2 Methods and compositions for the prevention and treatment of anemia |
| 01/15/2003 | EP1274727A1 Nk-2 homeobox transcription factor |
| 01/15/2003 | EP1274726A2 Therapeutic compounds and methods for modulating v3, a versican isoform |
| 01/15/2003 | EP1274720A1 Albumin fusion proteins |
| 01/15/2003 | EP1274719A2 Albumin fusion proteins |
| 01/15/2003 | EP1274675A1 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 01/15/2003 | EP1274464A2 Compositions and methods for regulated protein expression in gut |
| 01/15/2003 | EP1274451A1 Sperm factor oscillogenin |
| 01/15/2003 | EP1274450A2 Cytokine uses; compositions; methods |
| 01/15/2003 | EP1274353A1 A container assembly for fertilization and culture and embryo transfer and method of fertilization and culture employing such a container |
| 01/15/2003 | EP1274305A2 Aids ancestral viruses and vaccines |
| 01/15/2003 | EP1274301A2 Novel warming method of cryopreserved specimens |
| 01/15/2003 | EP1056835A4 Derivation of cells and tissues from embryonic pre-stem cells for transplantation therapies |
| 01/15/2003 | EP0979235A4 Isolated nucleic acid molecule coding for tumor rejection antigen precursors mage-c1 and mage-c2 and uses thereof |
| 01/15/2003 | EP0793511B1 Biopolymer foams having extracellular matrix particulates |
| 01/15/2003 | EP0749981B1 Monoclonal antibody specific for pd-ecgf / thymidine phosphorylase |
| 01/15/2003 | EP0671927B1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/15/2003 | CN1391610A BASB118 polypeptide and polynucleotide from moraxella catarrhalis |